Biopharmaceutical Company Secures $1.3M in Funding

Posted: Updated:
Elevate Ventures contributed to the round of funding. Elevate Ventures contributed to the round of funding.
INDIANAPOLIS -

Indianapolis-based Confluence Pharmaceuticals LLC has completed a $1.3 million round of funding. The company says Elevate Ventures, also based in Indianapolis, contributed to the financing as Confluence aims to develop therapeutic treatments for symptoms of Fragile X Syndrome and Autism Spectrum Disorders.

As part of the investment, Phil Lodato, general counsel with Elevate Ventures, will join the Confluence Pharmaceuticals board of directors.

"Confluence Pharmaceuticals has demonstrated a capital efficient approach to developing promising therapeutic assets to address an unmet need," said Chris LaMothe, chief executive officer of Elevate Ventures. "We are excited to add the company to our investment portfolio, especially given the life sciences sector’s contribution to our community."

Confluence Pharmaceuticals says it has already received Orphan Drug Designation in the U.S. and Europe and is seeking accelerated regulatory review with American and European agencies. According to the U.S. Food & Drug Administration, the designation is given to "drugs and biologics which are defined as those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the U.S., or that affect more than 200,000 persons but are not expected to recover the costs of developing and marketing a treatment drug."

Steve Johns, president of Confluence Pharmaceuticals, says the company is "intently focused" getting to the start of Phase 1 FDA human clinical trials.

  • Perspectives

    • (photo courtesy of Conexus)

      Getting the Word Out About Manufacturing & Logistics

      As the epicenter of the nation’s advanced manufacturing and logistics industries, Indiana has a compelling story to tell about how Hoosier companies make and move the goods people depend on every day. Our goal is to ensure everyone hears these stories – many of which share a common theme focused on cutting-edge technologies that are transforming the way products are made and moved around the world and the people who use them. Conexus Indiana launched an...

    More

Events



  • Most Popular Stories

    • (photo courtesy of The Times of Northwest Indiana)

      Historic Hospital to be Torn Down in Gary

      A building that once represented the racial divide in the city of Gary, but long provided health care to the African American community, will soon fall to a wrecking ball. The city says it intends to raze the long-abandoned St. John’s Hospital. 

    • Photo courtesy of Indianapolis Motor Speedway

      Red Bull to Discontinue Air Race World Championship

      The Red Bull Air Race at the Indianapolis Motor Speedway, originally scheduled for October, has been canceled as a result of Red Bull's decision to discontinue the Air Race World Championship following the 2019 season. The company says the races scheduled between June and September in Russia, Hungary and Japan will run as planned. 

    • On-Air

      Find out when and where you can watch and listen to our reports.

    • The Honda Greensburg plant opened in 2008.

      Honda to Invest $4M, Add Jobs at Greensburg Plant

      The American Honda Motor Co. continues to invest in its Greensburg, Indiana plant as it has announced the factory will be producing the company’s first electrified sport utility vehicle in the U.S. The company says it will invest more than $4 million and add 34 new jobs in the plant to support production of the CR-V Hybrid.  

    • Eleven Fifty was previously headquartered at Launch Fishers.

      Eleven Fifty to Cut Ribbon on New Location

      Eleven Fifty Academy will cut the ribbon on its new downtown location September 23. The nonprofit coding academy says it will host a grand opening ceremony November 6.